AC220-A-U302 trial

Clinical Trial Grant

Duke Scholars

Principal Investigator Thomas William LeBlanc Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Clinical Research Institute

Awarded By

Daiichi Sankyo Inc

Start Date

July 1, 2016

End Date

August 7, 2020

Administered By

Duke Clinical Research Institute

Awarded By

Daiichi Sankyo Inc

Start Date

July 1, 2016

End Date

August 7, 2020